Publications
Development of a high-throughput assay to identify inhibitors of the ubiquitin-conjugating enzyme UBCH10.SLAS Discov 2022-06-01;27(4):266-271.
YES, a novel therapeutic target in hepatocellular carcinoma.Mol Cell Oncol 2022-05-01;9(1):2069993.
ERK3-MK5 signaling regulates myogenic differentiation and muscle regeneration by promoting FoxO3 degradation.J Cell Physiol 2022-04-01;237(4):2271-2287.
Signaling by the tyrosine kinase Yes promotes liver cancer development.Sci Signal 2022-01-18;15(717):eabj4743.
Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential.Pharmacol Rev 2021-10-01;73(4):263-296.
Interleukin-17 Receptor D in Physiology, Inflammation and Cancer.Front Oncol 2021-03-23;11:656004.
Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis.Oncogene 2021-01-01;40(2):452-464.
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer.Nat Commun 2020-07-24;11(1):3701.
Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models.Mol. Cell. Biol. 2019-03-15;39(6).
A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors.PLoS ONE 2018-10-19;13(10):e0205585.
Suivez l'IRIC :